🦊/People

Ben Carter

Executive at Cytoseek

Bristol, England, United Kingdom

Find your path to Ben

41 people in our graph share verified history with Ben β€” schools, employers, funds. One of them is your warm intro.

About

Ben Carter is the CEO and Co-founder of Hone Bio, where he leads the company's development of lipid nanoparticle technologies for targeted delivery. His work focuses on delivery solutions for advanced therapies including mRNA and gene editing.

Executive at Cytoseek

Intro paths

β†’

In turn, Ben can intro founders to Cytoseek's investors below.

Cytoseek's investors Β· 1

Experience

  1. Hone BioChief Executive Officercurrent2024 β€” presentCity Of Bristol, England, United Kingdom
  2. CytoSeekChief Executive Officer2023 β€” 2024Bristol, England, United Kingdom
  3. CytoSeekHead of Technical Operations2018 β€” 2023
  4. University of BristolRSE Enterprise Fellowship2018 β€” 2019Bristol, United Kingdom
  5. University of BristolPostgraduate Researcher2014 β€” 2019

Skills & more

BiochemistryBusiness DevelopmentResearchMolecular BiologyChemistryCell CultureScientific WritingProgrammingCell BiologyProtein Expression
  • The Pharma Business Development Course (2-day course) with Stefan Fischer β€” CELforPharma
  • Transformational Leadership, 7-8 April 2022 β€” Executive Education at Cambridge Judge Business School
  • The Pharma Licensing Negotiation Course (2-day course) with Dr. Roger Cox β€” CELforPharma

From Ben's professional profile.

Frequently asked questions

Who is Ben Carter?
Ben Carter is the CEO and Co-founder of Hone Bio, where he leads the company's development of lipid nanoparticle technologies for targeted delivery. His work focuses on delivery solutions for advanced therapies including mRNA and gene editing.
Where did Ben Carter go to school?
Ben Carter studied at University of Bristol (Bachelor of Science (BSc), Biochemistry); St Bede's School, Redhill.

Same school

Shared employers